Medicus Pharma Ltd (NASDAQ:MDCX)

PRESS RELEASE

published on 10/13/2025 at 13:30, 1 month 22 days ago

Medicus Pharma Ltd. to Present at The Maxim Growth Summit 2025
Medicus Pharma Ltd. CEO to join fireside chat at Maxim Growth Summit, discussing clinical development programs of Skinject (skin diseases) and Teverelix (advanced prostate cancer)

Clinical Development Fireside Chat CEO Medicus Pharma Ltd. Maxim Growth Summit
BRIEF

published on 10/07/2025 at 13:35, 1 month 28 days ago

Medicus Pharma participera au sommet des family offices de Dubaï

Développement Clinique Intelligence Artificielle Innovations Biotechnologiques Medicus Pharma Sommet Des Family Offices
BRIEF

published on 10/07/2025 at 13:35, 1 month 28 days ago

Medicus Pharma to Participate in Dubai Family Office Summit

Artificial Intelligence Clinical Development Biotech Innovations Medicus Pharma Family Office Summit
PRESS RELEASE

published on 10/07/2025 at 13:30, 1 month 28 days ago

Medicus Pharma Ltd. to Present at the Family Office Summit in Dubai, UAE
Dr. Raza Bokhari, Executive Chairman & CEO of Medicus, to discuss biotech innovation and wealth transfer at Family Office Summit in Dubai

Biotech Innovation Family Office Summit Medicus Raza Bokhari Wealth Transfer
BRIEF

published on 09/29/2025 at 13:35, 2 months 5 days ago

Medicus Pharma Ltd. Gains FDA Support for Skinject Development

FDA Approval Clinical Trials Medicus Pharma Basal Cell Carcinoma Skinject Development
BRIEF

published on 09/29/2025 at 13:35, 2 months 5 days ago

Medicus Pharma Ltd. obtient le soutien de la FDA pour le développement de Skinject

Essais Cliniques Approbation De La FDA Medicus Pharma Carcinome Basocellulaire Développement De Skinject
PRESS RELEASE

published on 09/29/2025 at 13:30, 2 months 5 days ago

Medicus Pharma Ltd. Receives Positive Feedback From the Food and Drug Adminstration (FDA) Type C Meeting Supporting the Development of Skinject
FDA agrees to 505(b)(2) pathway for Medicus Pharma's Skinject D-MNA to treat BCC, positive Type C meeting feedback, SKNJCT-003 patient recruitment aims, EOP2 request in Q1 2026

FDA Clinical Study Medicus Pharma Skinject D-MNA BCC
BRIEF

published on 09/24/2025 at 13:35, 2 months 10 days ago

Medicus Pharma présente à Brookline Capital Markets

Essais Cliniques Medicus Pharma Teverelix D-MNA Carcinome Basocellulaire
BRIEF

published on 09/24/2025 at 13:35, 2 months 10 days ago

Medicus Pharma Presents at Brookline Capital Markets

Clinical Trials Medicus Pharma Teverelix D-MNA Basal Cell Carcinoma
PRESS RELEASE

published on 09/24/2025 at 13:30, 2 months 10 days ago

Medicus Pharma Ltd. To Present at Brookline Capital Markets
Medicus Pharma Ltd. to provide updates on D-MNA treatment for BCC and Teverelix. Fireside chat on Sep 29 to discuss key development programs and potential market opportunities

Fireside Chat Market Opportunities Medicus Pharma Ltd. Teverelix D-MNA

Published on 12/05/2025 at 02:35, 7 hours ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 7 hours 5 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 8 hours 35 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 10 hours 30 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 10 hours 35 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

Published on 12/05/2025 at 09:05, 29 minutes ago

Transforming Football: IBM and Bayer 04 Leverkusen Use AI for Superior Game Analysis
Published on 12/05/2025 at 09:00, 34 minutes ago

Original-Research: DEMIRE AG (von NuWays AG): BUY
Published on 12/05/2025 at 09:00, 35 minutes ago

SPECTRIS PLC - Removal
Published on 12/05/2025 at 09:00, 35 minutes ago

Official List Notice
Published on 12/05/2025 at 09:00, 35 minutes ago

Petershill Partners plc - Removal

View all EQS

Published on 12/05/2025 at 08:45, 50 minutes ago

Air Liquide va étendre et électrifier son unité de production d'oxygène à Shaanxi, soutenant ainsi l'engagement de la Chine à décarboner son industrie
Published on 12/05/2025 at 08:45, 50 minutes ago

Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/05/2025 at 08:42, 52 minutes ago

ENGIE - déclaration mensuelle du nombre total d'actions et de droits de vote composant le capital au 30 novembre 2025
Published on 12/04/2025 at 18:14, 15 hours 20 minutes ago

Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 15 hours 35 minutes ago

Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025

View all LES ECHOS COMFI WIRE

News